AstraZeneca bolsters obesity pipeline with promising early data for candidates
And the mental health benefits shouldn't be overlooked
However, despite the availability of sophisticated devices and suitable recommendations on proper injection techniques [4, 5], current literature reports a high rate of injection errors responsible for lipodystrophy (LD) [6] and consequent metabolic disorders [7, 8] by referring to different care settings and most often providing little information on lipohypertrophy (LH) identification methods [9,10,11]
2 Nevertheless, it has been found that despite eight available families of hypoglycemic compounds (biguanides, sulfonylureas, glinides, -glucosidase inhibitors, DPPIV inhibitors, GLP1 analogues, thiazolidinediones, and SGLT2 inhibitors), 3.0.CO;2-W 9
static.cigna.com [PDF] Evernorth Health Services